Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 5272531, 13 pages
http://dx.doi.org/10.1155/2016/5272531
Research Article

Calycosin and Formononetin Induce Endothelium-Dependent Vasodilation by the Activation of Large-Conductance Ca2+-Activated K+ Channels (BKCa)

1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau
2Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong
3National Institute of Complementary Medicine, Western Sydney University, Penrith, NSW, Australia
4School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

Received 5 July 2016; Revised 26 September 2016; Accepted 19 October 2016

Academic Editor: Kuzhuvelil B. Harikumar

Copyright © 2016 Hisa Hui Ling Tseng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X.-L. Xu, H. Ji, S.-Y. Gu, Q. Shao, Q.-J. Huang, and Y.-P. Cheng, “Cardioprotective effects of Astragali Radix against isoproterenol-induced myocardial injury in rats and its possible mechanism,” Phytotherapy Research, vol. 22, no. 3, pp. 389–394, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. L. Miller, “Botanical influences on cardiovascular disease,” Alternative Medicine Review, vol. 3, no. 6, pp. 422–431, 1998. View at Google Scholar · View at Scopus
  3. Y.-H. Jiang, W. Sun, W. Li et al., “Calycosin-7-O-β-D-glucoside promotes oxidative stress-induced cytoskeleton reorganization through integrin-linked kinase signaling pathway in vascular endothelial cells,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, article 315, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Sun, J. Wang, L.-H. Huang, and Y.-X. Cao, “Antihypertensive effect of formononetin through regulating the expressions of eNOS, 5-HT2A/1B receptors and α1-adrenoceptors in spontaneously rat arteries,” European Journal of Pharmacology, vol. 699, no. 1–3, pp. 241–249, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Sun, R. Liu, and Y.-X. Cao, “Vasorelaxant and antihypertensive effects of formononetin through endothelium-dependent and -independent mechanisms,” Acta Pharmacologica Sinica, vol. 32, no. 8, pp. 1009–1018, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-H. Wu, Q. Li, M.-Y. Wu et al., “Formononetin, an isoflavone, relaxes rat isolated aorta through endothelium-dependent and endothelium-independent pathways,” Journal of Nutritional Biochemistry, vol. 21, no. 7, pp. 613–620, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. X.-L. Wu, Y.-Y. Wang, J. Cheng, and Y.-Y. Zhao, “Calcium channel blocking activity of calycosin, a major active component of Astragali Radix, on rat aorta,” Acta Pharmacologica Sinica, vol. 27, no. 8, pp. 1007–1012, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Zhu, L. Zou, J. Tian, F. Lin, J. He, and J. Hou, “Protective effects of sulphonated formononetin in a rat model of cerebral ischemia and reperfusion injury,” Planta Medica, vol. 80, no. 4, pp. 262–268, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Fu, Y. Gu, J.-Q. Jiang et al., “Calycosin-7-O-β-d-glucoside regulates nitric oxide /caveolin-1/matrix metalloproteinases pathway and protects blood-brain barrier integrity in experimental cerebral ischemia-reperfusion injury,” Journal of Ethnopharmacology, vol. 155, no. 1, pp. 692–701, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. K.-T. Kang, “Endothelium-derived relaxing factors of small resistance arteries in hypertension,” Toxicological Research, vol. 30, no. 3, pp. 141–148, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. H. D. Intengan and E. L. Schiffrin, “Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants,” Hypertension, vol. 36, no. 3, pp. 312–318, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. C. J. Garland and K. A. Dora, “EDH: endothelium-dependent hyperpolarization and microvascular signalling,” Acta Physiologica, 2016. View at Publisher · View at Google Scholar
  13. I. Grgic, B. P. Kaistha, J. Hoyer, and R. Köhler, “Endothelial Ca2+-activated K+ channels in normal and impaired EDHF-dilator responses-relevance to cardiovascular pathologies and drug discovery,” British Journal of Pharmacology, vol. 157, no. 4, pp. 509–526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. C. G. Sobey, “Potassium channel function in vascular disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 1, pp. 28–38, 2001. View at Publisher · View at Google Scholar
  15. R. Köhler, B. P. Kaistha, and H. Wulff, “Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease,” Expert Opinion on Therapeutic Targets, vol. 14, no. 2, pp. 143–155, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Dalsgaard, C. Kroigaard, and U. Simonsen, “Calcium-activated potassium channels—a therapeutic target for modulating nitric oxide in cardiovascular disease?” Expert Opinion on Therapeutic Targets, vol. 14, no. 8, pp. 825–837, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Dalsgaard, C. Kroigaard, M. Misfeldt, T. Bek, and U. Simonsen, “Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles,” British Journal of Pharmacology, vol. 160, no. 6, pp. 1496–1508, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Nilius, F. Viana, and G. Droogmans, “Ion channels in vascular endothelium,” Annual Review of Physiology, vol. 59, pp. 145–170, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Jackson-Weaver, J. M. Osmond, M. A. Riddle et al., “Hydrogen sulfide dilates rat mesenteric arteries by activating endothelial large-conductance Ca2+-activated K+ channels and smooth muscle Ca2+ sparks,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 304, no. 11, pp. H1446–H1454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Vang, J. Mazer, B. Casserly, and G. Choudhary, “Activation of endothelial BKCa channels causes pulmonary vasodilation,” Vascular Pharmacology, vol. 53, no. 3-4, pp. 122–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. C. Xu, G. P. H. Leung, P. Y. D. Wong, P. M. Vanhoutte, and R. Y. K. Man, “Kaempferol stimulates large conductance Ca2+-activated K+ (BKCa) channels in human umbilical vein endothelial cells via a cAMP/PKA-dependent pathway,” British Journal of Pharmacology, vol. 154, no. 6, pp. 1247–1253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Begg, F.-M. Mo, L. Offertáler et al., “G Protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ Current,” Journal of Biological Chemistry, vol. 278, no. 46, pp. 46188–46194, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Félétou, “Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?” British Journal of Pharmacology, vol. 156, no. 4, pp. 545–562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Chang, L. Wu, and R. Wang, “Altered expression of BK channel β1 subunit in vascular tissues from spontaneously hypertensive rats,” American Journal of Hypertension, vol. 19, no. 7, pp. 678–685, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. L. Carvalho-de-Souza, W. A. Varanda, R. C. Tostes, and A. Z. Chignalia, “BK channels in cardiovascular diseases and aging,” Aging and Disease, vol. 4, no. 1, pp. 38–49, 2013. View at Google Scholar · View at Scopus
  26. S. Brakemeier, I. Eichler, A. Knorr, T. Fassheber, R. Köhler, and J. Hoyer, “Modulation of Ca2+-activated K+ channel in renal artery endothelium in situ by nitric oxide and reactive oxygen species,” Kidney International, vol. 64, no. 1, pp. 199–207, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Liu and D. D. Gutterman, “The coronary circulation in diabetes: influence of reactive oxygen species on K+ channel-mediated vasodilation,” Vascular Pharmacology, vol. 38, no. 1, pp. 43–49, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. R. White and C. R. Hiley, “A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery,” British Journal of Pharmacology, vol. 122, no. 8, pp. 1573–1584, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Li, W. Jie, L. Huang et al., “Nuclear BK channels regulate gene expression via the control of nuclear calcium signaling,” Nature Neuroscience, vol. 17, no. 8, pp. 1055–1063, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Tep-areenan, D. A. Kendall, and M. D. Randall, “Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels,” British Journal of Pharmacology, vol. 135, no. 3, pp. 735–740, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. H.-J. Park, Y. Zhang, S. P. Georgescu, K. L. Johnson, D. Kong, and J. B. Galper, “Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis,” Stem Cell Reviews, vol. 2, no. 2, pp. 93–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. U. Förstermann and W. C. Sessa, “Nitric oxide synthases: regulation and function,” European Heart Journal, vol. 33, no. 7, pp. 829–837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Bachetti, L. Comini, S. Curello et al., “Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells,” Journal of Molecular and Cellular Cardiology, vol. 37, no. 5, pp. 939–945, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. C. M. Fanger, S. Ghanshani, N. J. Logsdon et al., “Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1,” The Journal of Biological Chemistry, vol. 274, no. 9, pp. 5746–5754, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Wu, S. W. Annie Bligh, L.-H. Gu et al., “Simultaneous determination of six isoflavonoids in commercial Radix Astragali by HPLC-UV,” Fitoterapia, vol. 76, no. 2, pp. 157–165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Zhao, B.-N. Chen, S.-B. Wang, S.-H. Wang, and G.-H. Du, “Vasorelaxant effect of formononetin in the rat thoracic aorta and its mechanisms,” Journal of Asian Natural Products Research, vol. 14, no. 1, pp. 46–54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A. M. Briones, A. S. Padilha, A. L. Cogolludo et al., “Activation of BKCa channels by nitric oxide prevents coronary artery endothelial dysfunction in ouabain-induced hypertensive rats,” Journal of Hypertension, vol. 27, no. 1, pp. 83–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. J. M. Hughes, M. A. Riddle, M. L. Paffett, L. V. Gonzalez Bosc, and B. R. Walker, “Novel role of endothelial BK Ca channels in altered vasoreactivity following hypoxia,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 299, no. 5, pp. H1439–H1450, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Calderone, A. Martelli, L. Testai, E. Martinotti, and M. C. Breschi, “Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 375, no. 1, pp. 73–80, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Cui, D. H. Cox, and R. W. Aldrich, “Intrinsic voltage dependence and Ca2+ regulation of mslo large conductance Ca-activated K+ channels,” Journal of General Physiology, vol. 109, no. 5, pp. 647–673, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Iadecola, “Neurovascular regulation in the normal brain and in Alzheimer's disease,” Nature Reviews Neuroscience, vol. 5, no. 5, pp. 347–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Yamamoto, Y. Ueta, L. Wang et al., “Suppression of a neocortical potassium channel activity by intracellular amyloid-β and its rescue with homer1a,” Journal of Neuroscience, vol. 31, no. 31, pp. 11100–11109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Wang, H. Kang, Y. Li et al., “Cognitive recovery by chronic activation of the large-conductance calcium-activated potassium channel in a mouse model of Alzheimer's disease,” Neuropharmacology, vol. 92, pp. 8–15, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. H. H. Dietrich, C. Xiang, B. H. Han, G. J. Zipfel, and D. M. Holtzman, “Soluble amyloid-β, effect on cerebral arteriolar regulation and vascular cells,” Molecular Neurodegeneration, vol. 5, no. 1, article 15, 2010. View at Publisher · View at Google Scholar · View at Scopus